Bioactivation of mushroom hydrazines to mutagenic products by mammalian and fungal enzymes

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 381, Issue 1, 1997, Pages 131-139

  Walton, Kim ^a   Coombs, Maurice M ^a   Walker, Ron ^a   Ioannides, Costas ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

Agaricus bisporus; Agaritine; Bioactivation; Chemical carcinogens; Hydrazines; Mushroom; Polyphenol oxidase; Tyrosinase

Indexed keywords

AGARITINE; CATECHOL OXIDASE; ENZYME; HYDRAZINE DERIVATIVE; MONOPHENOL MONOOXYGENASE; UNCLASSIFIED DRUG;

AMES TEST; ARTICLE; CHEMICAL MODIFICATION; MUSHROOM; MUTAGENIC ACTIVITY; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL; SALMONELLA;

AGARICUS; ANIMALS; AROCLOR 1254; AROCLORS; BENZOATES; BENZOIC ACIDS; BIOTRANSFORMATION; CYTOSOL; DOSE-RESPONSE RELATIONSHIP, DRUG; HYDRAZINES; LIVER; MALE; MICROSOMES, LIVER; MONOPHENOL MONOOXYGENASE; MUTAGENICITY TESTS; MUTAGENS; PHENYLHYDRAZINES; RATS; RATS, SPRAGUE-DAWLEY; SALMONELLA TYPHIMURIUM;

AGARICUS BISPORUS; BASIDIOMYCOTA; MAMMALIA; SALMONELLA; SALMONELLA TYPHIMURIUM; TYPHIMURIUM;

EID: 0030782510     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(97)00160-7     Document Type: Article

References (25)

1. R.A. Prough and S.J. Moloney, Hydrazines, in: Bioactivation of Foreign Compounds, Academic Press, Inc., 1985, pp. 433-449.
2. Toth B. Mushroom toxins and cancer. Int. J. Oncol. 6:1995;137-145.
3. Gry J., Pilegaard K. Hydrazines in the cultivated mushroom (Agaricus bisporus). Vår Föda. 43(Supplement 1):1991;1-38.
4. Toth B., Erickson J. Cancer induction in mice by feeding of the uncooked cultivated mushroom of commerce Agaricus bisporus. Cancer Res. 46:1986;4007-4011.
5. Toth B., Patil K., Pyysalo H., Stessman C., Gannett P. Cancer induction in mice by feeding the raw false morel mushroom Gyormitra esculenta. Cancer Res. 52:1992;2279-2284.
6. Liu J.W., Beelman R.B., Lineback D.R., Speroni J.J. Agaritine content of fresh and processed mushrooms. J. Fd. Sci. 47:1982;1542-1548.
7. Friederich U., Fischer B., Luthy J., Hann T., Schlatter C., Würgler F.E. The mutagenicity of agaritine - a constituent of the cultivated mushroom Agaricus bisporus - and its derivatives detected with the Salmonella mammalian microsome assay (Ames test). Z. Lebensm. Unters. Forsch. 183:1986;85-89.
8. Rogan E.G., Walker B.A., Gingell R., Nagel D.L., Toth B. Microbial mutagenicity of selected hydrazines. Mut. Res. 102:1982;413-424.
9. Papaparaskeva-Petrides C., Ioannides C., Walker R. Contribution of phenolic and quinonoid structures in the mutagenicity of the edible mushroom Agaricus bisporus. Fd. Chem. Toxic. 31:1993;561-567.
10. K. Walton, M.M. Coombs, F.S. Catterall, R. Walker and C. Ioannides, Bioactivation of the mushroom hydrazine, agaritine, to intermediates that bind covalently to proteins and induce mutations in the Ames test, Carcinogenesis (1977) submitted for publication.
11. Sterner O., Bergman R., Kesler E., Magnuson G., Nilsson L., Wickberg B., Zimerson E., Zetterberg G. Mutagens in larger fungi: I forty eight species screened for mutagenic activity in the Salmonella/microsome assay Mut. Res. 101:1982;269-281.
12. von Wright A., Knuutinen J., Lindroth S., Pellinen M., Widen K.-G., Seppa E.-L. The mutagenicity of some edible mushrooms in the Ames test. Fd. Chem. Toxic. 20:1982;265-267.
13. Papaparaskeva C., Ioannides C., Walker R. Agaritine does not mediate the mutagenicity of the edible mushroom Agaricus bisporus. Mutagenesis. 6:1991;213-217.
14. Wallcave R., Nagel D.L., Raha C.R., Hwan-Soo J., Bronczyk S., Kupper R., Toth B. An improved synthesis of agaritine. J. Org. Chem. 44:1979;3752-3755.
15. Toth B., Nagel D., Patil K., Erickson J., Antonson K. Tumor induction with the N′-acetyl derivative of 4-hydroxymethylphenylhydrazine, a metabolite of agaritine of Agaricus bisporus. Cancer Res. 38:1978;177-180.
16. Toth B., Patil K., Jae H.S. Carcinogenesis of 4-(hydroxymethyl) benzenediazoniun ion (tetrafluoroborate) of Agaricus bisporus. Cancer Res. 41:1981;2444-2449.
17. Ioannides C., Parke D.V. Mechanism of induction of hepatic drug metabolising enzymes by a series of barbiturates. J. Pharm. Pharmacol. 27:1975;739-749.
18. Maron D.M., Ames B.N. Revised methods for the Salmonella mutagenicity test. Mutat. Res. 113:1983;173-215.
19. De Flora S., Cajelli E., Brambilla G. Mutagenicity of an Agaricus bisporus extract. ICRS Med. Sci. 7:1979;185.
20. Patrineli A., Clifford M.N., Ioannides C. Contribution of phenols, quinones and reactive oxygen species to the mutagenicity of white grape juice in the Ames test. Fd. Chem. Tox. 34:1996;869-872.
21. Levenberg B. Structure and enzymatic cleavage of agaritine, a phenylhydrazide of L-glutamic acid isolated form agaricaceae. J. Am. Chem. Soc. 83:1961;503-504.
22. Ross A.E., Nagel D.L., Toth B. Occurrence, stability and decomposition of β-N-[γ-L(+)glutamyl]-4-hydroxymethylphenylhydrazine (agaritine) from the mushroom Agaricus bisporus. Fd. Chem. Toxic. 20:1982;903-907.
23. Hiramoto K., Kaku M., Kato T., Kigukawa K. DNA strand breaking by the carbon-centered radical generated form 4-(hydroxymethyl) benzene diazonium salt, a carcinogen in mushroom Agaricus bisporus. Chem.-Biol. Interactions. 94:1995;21-36.
24. Boekelheide K., Doyle G.G., Mize P.D., Vogel F.S. The role of γ-glutamyl transpeptidase in the nephrotoxicity of an Agaricus bisporus metabolite. Am. J. Pathol. 100:1980;651-662.
25. Sanchez-Ferrer A., Rodriguez-Lopez J.N., Garcia-Canovas F., Garcia-Carmona F. Tyrosinase: a comprehensive review of its mechanism. Biochim. Biophys. Acta. 1247:1995;1-11.